Astrazeneca PLC (NYSE:AZN) Quarterly Basic Net EPS At 2016-03-31

0

For the year ended 2016-03-31 Astrazeneca PLC (NYSE:AZN) basic consolidated EPS came $2.2358. Conversely, for the quarter ended 2016-03-31, it was $2.2358.

EPS can be simply called as a fraction of profits that is disbursed against each outstanding share. It is measured using the formula – net profit/outstanding shares. The element ‘Per-share earnings’ is majorly utilized by market experts to give earnings and price projections. Suppose a group “S” announces a net profit of $15,000 in a given year. The count of outstanding shares is 300. So, its EPS will be $50. EPS is issued every quarter, indicating the stakeholders can evaluate the financial performance periodically.

EPS alone cannot indicate on the financial well-being of a firm. For a clear picture, it is vital to look into the price to earnings ratio of company.

EPS from continuing operations

Astrazeneca PLC (NYSE:AZN) EPS from continuing operations was $2.2358 for the fiscal ended 2016-03-31. For the quarter ended 2016-03-31, this figure was $2.2358.

EPS contribution from parent

Astrazeneca PLC (NYSE:AZN) confirmed basic EPS of $2.235 for the year ended 2016-03-31 from its parent group. Conversely, for the quarter closed 2016-03-31 it was $2.235.

Basic net EPS

Astrazeneca PLC (NYSE:AZN) basic net EPS was $0.51 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it came at $0.51.

Consolidated diluted EPS

Astrazeneca PLC (NYSE:AZN) consolidated diluted EPS was 2.234 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it stood at $2.234.

Basic diluted EPS

Astrazeneca PLC (NYSE:AZN) basic diluted EPS was $0.4941 for the quarter ended 2016-03-31. For the year ended 2016-03-31, basic diluted EPS was $0.4941.

Net diluted EPS

Astrazeneca PLC (NYSE:AZN) posted net diluted EPS of $2.23 for the fiscal closed 2016-03-31. For the quarter ended 2016-03-31, net diluted EPS was $2.23.

Diluted EPS from parent

Astrazeneca PLC (NYSE:AZN) diluted EPS from parent group was $2.2332 for the year ended 2016-03-31. For the quarter ended 2016-03-31 it stood at $2.2332.

Astrazeneca PLC (NYSE:AZN) net basic EPS was $2.23 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it was $2.23.

For the year ended 2016-03-31, basic shares outstanding were 1264 while for the quarter ended 2016-03-31 is 1264.

For the fiscal ended 2016-03-31, the diluted outstanding shares were 1264 and for the quarter ended 2016-03-31 it was 1264.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 3 times, 1 visits today)